Scientific Officer (Target Biology and Genomic Instability)

26/09/2019, 23:55

Sutton
Cancer Therapeutics
Directorate Cancer Therapeutics
Full time
Fixed Term
2 years
35
Circa £26,000
The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. We provided the first convincing evidence that DNA damage is the basic cause of cancer, laying the foundation for the now universally accepted idea that cancer is a genetic disease. Today, The Institute of Cancer Research (ICR) leads the world at isolating cancer-related genes and discovering new targeted drugs for personalised cancer treatment.

Under the leadership of our Chief Executive, Professor Paul Workman FRS, the ICR is ranked as the UK’s leading academic research centre. Together with our partner The Royal Marsden, we are rated in the top four cancer centres globally.

The ICR is committed to attracting, developing and retaining the best minds in the world to join us in our mission – to make the discoveries that defeat cancer.

The new team led by Dr Anderson Wang is looking for an enthusiastic Scientific Officer to help their work on genomic instability in cancer. This position is critical for strengthening our drug discovery portfolio and supporting biology teams within the CRUK Cancer Therapeutics Unit in Sutton. 

The post holder is required to have a first degree in a biological science or physical science, and to have extensive experience in tissue culture, cell biology, biochemistry and in particular CRISPR/Cas gene editing technology. Please refer to the attached job description and person-specification for full details.

This appointment is for two years in the first instance. Starting salary will be based on previous experience. (Please note we are also looking for a more experienced Higher Scientific Officer  -  job ref 838)

We consider all applications on merit and have a strong commitment to enhancing the diversity of our staff.

In partnership with

Cancer Research UK
Additional Documentation for Candidates